Abstract:Background: Benzodiazepines (BZDs) and Z-drugs have been widely used in clinical practice and there have been limited data from large populations about hazardous BZDs and Z-drugs use and its correlates in patients with mental disorder. The study aimed to assess the current status of hazardous BZDs and Z-drugs use and its related factors via analysis of prescriptions in outpatient psychiatric settings in China.Methods: The study included outpatients who were prescribed at least one BZDs or Z-drugs from 5 psychiatric settings in the east, central and west regions of China in 2018. Demographic and prescription information were extracted from the electronic prescription dispensing database. We defined the co-occurence of overdose [>40mg Diazepam Milligram Equivalence (DME)] and long-term use (>consecutive 90 days) as the hazardous hypnotics use, and patients whose recorded diagnoses did not meet any indications in Chinese FDA as the over-indication users. In addition, 200 patients who were detected as hazardous users in one of the hospitals in the east region were randomly selected for follow-up interview to confirm the actual situation.Findings: Among the 720 054 outpatients in 2018, 164 450 (22·8%) patients had at least one BZDs or Z-drugs prescription. Most of the patients were females (63·6%) and were aged 18 to 64 (76·2%). Of the total patients, 55·9% patients were prescribed with over-indication use and 3% were defined as hazardous users. Multivariate logistic regression shown that factors associated with a greater likelihood of hazardous use were older age (aOR[>65]: 5·05; 95%CI: 3·24-8·40), male gender (aOR: 1·20; 95%CI: 1·13-1·28), west region (aOR 1·13; 95%CI: 1·05-1·22), over-indications use (aOR 3·09; 95%CI: 2·82-3·39), a more frequent outpatient visit (aOR 1·06; 95%CI: 1·06-1·07), a greater number of different doctors visits (aOR 1·23; 95%CI: 1·22-1·24), and patients diagnosed particularly as Behavioral syndromes associated with physiological disturbances and physical factors (aOR 3·65; 95%CI:3·07-4·30), Epilepsy and recurrent seizures (aOR 5·22; 95%CI: 4·29-6·30) and Sleep disorders (aOR 1·85; 95%CI: 1·67-2·04). 98·5% (197/200) of patients at hazardous use risk cannot be effectively accessed because they registered the wrong contact information in the outpatient system (72·5%) or refused to be followed up (26%), and one of three patients who completed the interview met the DSM-5 criteria for Sedative hypnotics dependence syndrome.Interpretation: Sedative hypnotic drugs are commonly used clinically, and there are relatively large proportion of over-indication users in outpatients psychiatric settings in China. Whereas, a small proportion of patients at risk of hazardous BZDs and Z-drugs use (long-term and high-dose use) were detected by prescription data. The question raised by this study is how to use prescription data to support improvements in clinical practice.Funding: National Natural Science Foundation of China, Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center Clinical Research Center and Shanghai Municipal Health Commission.Declaration of Interest: None to declare. Ethical Approval: The study was approved and monitored by Shanghai Mental Health Center (permission number: 2019-22)

A cross-sectional study on populations of BZDs prescribed in community clinic

Clinical and Social Determinants of Long-Term Use of Benzodiazepines and its Impact on Quality of Life of Chinese Schizophrenia Patients

Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China: Long-Term Benzodiazepine Use in Patients With Major Depressive Disorder in China

The current state of benzodiazepines and Z-drugs use and their influences on bipolar disorder outcomes-A small sample analysis

Hazardous Use of Benzodiazepine and Z-Drugs in Psychiatric Clinics in China: An Electronic Prescription Database Study

Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder

Short- and Long-Term Influences of Benzodiazepine and Z-Drug Use in Patients with Bipolar Disorder Combined Sleep Disturbance During Affective Period: A Nine-Month Follow-Up Analysis

Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: electronic prescription database study

Benzodiazepine Receptor Agonists Prescribing for Insomnia among Adults in Primary Health Care Facilities in Beijing, China

Use of Benzodiazepine in Middle School Students

0424 Evaluating Sedative-Hypnotics Education Across Diverse Communities Using Community Alignment Theory

Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z‐Drugs Among Older Adults With Insomnia?

Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study

A Multilevel Cross-Sectional Study of Mental Disorder in Community Settings in Zhejiang Province

Potentially inappropriate use of benzodiazepines and z-drugs in the older population—analysis of associations between long-term use and patient-related factors

The prevalence of insomnia, its sociodemographic and clinical correlates, and treatment in rural and urban regions of Beijing, China: a general population-based survey.

Psychiatric Morbidity in Dependent Z-Drugs and Benzodiazepine Users

Trends in Prescriptions for Insomnia in a Province in China Between 2015 and 2019

0720 Depression and pain are barriers to benzodiazepine and z-drug deprescribing

Consumption patterns and factors associated with inappropriate prescribing of benzodiazepines in Primary Health Care settings

Chronic benzodiazepine usage among older people: prevalence, indications, and treatment modifications in patients admitted to an acute geriatric unit